Back to User profile » Dr Eva Ehrnrooth
Paper published by Dr Eva Ehrnrooth:
Original Research
Afatinib vs erlotinib for second-line treatment of Chinese patients with advanced squamous cell carcinoma of the lung
Lu S, Li W, Zhou C, Hu CP, Qin S, Cheng G, Feng J, Wang J, Cseh A, Peil B, Gibson N, Ehrnrooth E, Zhang L
OncoTargets and Therapy 2018, 11:8565-8573
Published Date: 30 November 2018